Curaleaf: Tough Quarter, But Help Is On The Way


  • Curaleaf reported Q3'22 revenues grew 7% to reach $340 million.
  • The MSO recently closed the Tryke deal and opened a third store in New Jersey to provide near-term growth drivers.
  • Management is confident about the SAFE Plus Act passing after years of no federal progress.
  • The stock is cheap at 8x normalized EBITDA targets, especially with a major catalyst ahead.
  • This idea was discussed in more depth with members of my private investing community, Out Fox The Street. Learn More » 

Most investors know the US cannabis market has been tough this year due to tough regulations and inflationary pressures hurting consumer spending on discretionary items. Curaleaf Holdings (OTCPK:CURLF) continues to feel the pressure, but the stock isn't accurately priced for the growth opportunity ahead. My investment thesis remains ultra Bullish on the large MSO (multi-state operator) trading at a cheap valuation heading into some potential regulatory changes.

Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 


Popular posts from this blog

Kohl's: Worth $75 Without Financial Engineering

Stat of the Day: Leading Indicators Jump Again

Out Fox The $treet - December 13, 2019